An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success

IF 4.703 3区 材料科学 Nanoscale Research Letters Pub Date : 2023-12-19 DOI:10.1186/s11671-023-03913-6
Pragati Ramesh Kumbhar, Prakash Kumar, Aarti Lasure, Ravichandiran Velayutham, Debabrata Mandal
{"title":"An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success","authors":"Pragati Ramesh Kumbhar,&nbsp;Prakash Kumar,&nbsp;Aarti Lasure,&nbsp;Ravichandiran Velayutham,&nbsp;Debabrata Mandal","doi":"10.1186/s11671-023-03913-6","DOIUrl":null,"url":null,"abstract":"<div><p>The recent development of nanotechnology-based formulations improved the diagnostics and therapies for various diseases including cancer where lack of specificity, high cytotoxicity with various side effects, poor biocompatibility, and increasing cases of multi-drug resistance are the major limitations of existing chemotherapy. Nanoparticle-based drug delivery enhances the stability and bioavailability of many drugs, thereby increasing tissue penetration and targeted delivery with improved efficacy against the tumour cells. Easy surface functionalization and encapsulation properties allow various antigens and tumour cell lysates to be delivered in the form of nanovaccines with improved immune response. The nanoparticles (NPs) due to their smaller size and associated optical, physical, and mechanical properties have evolved as biosensors with high sensitivity and specificity for the detection of various markers including nucleic acids, protein/antigens, small metabolites, etc. This review gives, initially, a concise update on drug delivery using different nanoscale platforms like liposomes, dendrimers, polymeric &amp; various metallic NPs, hydrogels, microneedles, nanofibres, nanoemulsions, etc. Drug delivery with recent technologies like quantum dots (QDs), carbon nanotubes (CNTs), protein, and upconverting NPs was updated, thereafter. We also summarized the recent progress in vaccination strategy, immunotherapy involving immune checkpoint inhibitors, and biomarker detection for various cancers based on nanoplatforms. At last, we gave a detailed picture of the current nanomedicines in clinical trials and their possible success along with the existing approved ones. In short, this review provides an updated complete landscape of applications of wide NP-based drug delivery, vaccinations, immunotherapy, biomarker detection &amp; imaging for various cancers with a predicted future of nanomedicines that are in clinical trials.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":715,"journal":{"name":"Nanoscale Research Letters","volume":"18 1","pages":""},"PeriodicalIF":4.7030,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s11671-023-03913-6.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanoscale Research Letters","FirstCategoryId":"88","ListUrlMain":"https://link.springer.com/article/10.1186/s11671-023-03913-6","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The recent development of nanotechnology-based formulations improved the diagnostics and therapies for various diseases including cancer where lack of specificity, high cytotoxicity with various side effects, poor biocompatibility, and increasing cases of multi-drug resistance are the major limitations of existing chemotherapy. Nanoparticle-based drug delivery enhances the stability and bioavailability of many drugs, thereby increasing tissue penetration and targeted delivery with improved efficacy against the tumour cells. Easy surface functionalization and encapsulation properties allow various antigens and tumour cell lysates to be delivered in the form of nanovaccines with improved immune response. The nanoparticles (NPs) due to their smaller size and associated optical, physical, and mechanical properties have evolved as biosensors with high sensitivity and specificity for the detection of various markers including nucleic acids, protein/antigens, small metabolites, etc. This review gives, initially, a concise update on drug delivery using different nanoscale platforms like liposomes, dendrimers, polymeric & various metallic NPs, hydrogels, microneedles, nanofibres, nanoemulsions, etc. Drug delivery with recent technologies like quantum dots (QDs), carbon nanotubes (CNTs), protein, and upconverting NPs was updated, thereafter. We also summarized the recent progress in vaccination strategy, immunotherapy involving immune checkpoint inhibitors, and biomarker detection for various cancers based on nanoplatforms. At last, we gave a detailed picture of the current nanomedicines in clinical trials and their possible success along with the existing approved ones. In short, this review provides an updated complete landscape of applications of wide NP-based drug delivery, vaccinations, immunotherapy, biomarker detection & imaging for various cancers with a predicted future of nanomedicines that are in clinical trials.

Graphical abstract

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于纳米技术的癌症给药、免疫疗法、疫苗接种、成像和生物标记检测的最新情况:近期趋势和未来方向,以及临床成功案例
现有化疗的主要局限是缺乏特异性、细胞毒性大且有各种副作用、生物相容性差以及越来越多的多重耐药性病例。以纳米粒子为基础的给药技术提高了许多药物的稳定性和生物利用度,从而增加了组织渗透和靶向给药,提高了对肿瘤细胞的疗效。易于表面功能化和封装的特性使各种抗原和肿瘤细胞裂解物可以以纳米疫苗的形式递送,并提高免疫反应。纳米颗粒(NPs)因其较小的尺寸以及相关的光学、物理和机械特性,已发展成为具有高灵敏度和特异性的生物传感器,用于检测各种标记物,包括核酸、蛋白质/抗原、小代谢物等。本综述首先简要介绍了利用脂质体、树枝状聚合物、聚合物&、各种金属 NPs、水凝胶、微针、纳米纤维、纳米乳液等不同纳米级平台给药的最新情况。此外,我们还介绍了量子点(QDs)、碳纳米管(CNTs)、蛋白质和上转换 NPs 等最新技术的药物传输。我们还总结了疫苗接种策略、涉及免疫检查点抑制剂的免疫疗法以及基于纳米平台的各种癌症生物标记物检测的最新进展。最后,我们详细介绍了目前正在进行临床试验的纳米药物及其可能的成功案例,以及现有的已获批准的纳米药物。总之,这篇综述提供了基于宽纳米粒子的药物递送、疫苗接种、免疫疗法、生物标记物检测和amp;各种癌症成像应用的最新完整图景,并预测了正在进行临床试验的纳米药物的未来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nanoscale Research Letters
Nanoscale Research Letters NANOSCIENCE & NANOTECHNOLOGY-MATERIALS SCIENCE, MULTIDISCIPLINARY
CiteScore
15.00
自引率
0.00%
发文量
110
审稿时长
2.5 months
期刊介绍: Nanoscale Research Letters (NRL) provides an interdisciplinary forum for communication of scientific and technological advances in the creation and use of objects at the nanometer scale. NRL is the first nanotechnology journal from a major publisher to be published with Open Access.
期刊最新文献
Novel loading protocol combines highly efficient encapsulation of exogenous therapeutic toxin with preservation of extracellular vesicles properties, uptake and cargo activity Viscoelastic modelling and analysis of two-dimensional woven CNT-based multiscale fibre reinforced composite material system InGaN blue resonant cavity micro-LED with RGY quantum dot layer for broad gamut, efficient displays Transport properties of mechanochemically synthesized copper (I) selenide for potential applications in energy conversion and storage Photodynamic impact of curcumin enhanced silver functionalized graphene nanocomposites on Candida virulence
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1